Keytrda “still reigns” after the interim analysis for Akeso and Summit Therapeutics (SMMT)’ PD-1/VEGF “muddies the outlook” for a potential ivonescimab survival benefit in non-small cell lung cancer.

Shares of Bank of Montreal BMO rallied 1.28% to C$132.32 Thursday, in what proved to be an all-around favorable trading ...

BMO Capital raised the firm’s price target on Newmont (NEM) to $64 from $63 and keeps an Outperform rating on the shares after its Q1 earnings ...

Bank of Montreal is the third-largest bank in Canada by market cap, following RBC and TD Bank. Read why I think BMO stock is ...

Stock futures are little changed Wednesday night after a steep sell-off in the prior session. Futures tied to the Dow Jones ...

(Reuters) -Eli Lilly said on Thursday its experimental pill, orforglipron, led to a weight loss of nearly 8% at the highest ...

BEIJING — China announced countermeasures on Friday, raising tariffs on U.S. goods from 84% to 125% starting Saturday. The U.S. and China have escalated trade war by raising tariffs even as U.S.

On Friday, BMO Capital Markets highlighted an opportunity in Canadian midstream stocks following a recent decline in oil prices. Analyst Ben Pham from BMO Capital pointed out that the dip in ...

The mounting uncertainty has now prompted BMO Capital Markets to lower its year-end target for the benchmark index. “We are revising our 2025 year-end S&P 500 price targets down to 6,100 from 6,700.

NEW YORK (Reuters) - BMO Capital on Wednesday cut its year-end 2025 S&P 500 target by 9% to 6,100 from the prior 6,700, citing the speed and severity of the recent selloff. In a note to clients ...